Abezino Tablet

Abezino 150 mg Tablet সম্পর্কে

বাংলাদেশে Abezino 150 mg Tablet ট্যাবলেট হিসেবে পাওয়া যায়; এতে Abemaciclib আছে (১৫০ mg)। Abemaciclib-এর অন্য ব্র্যান্ডগুলো এই পাতায় কম দাম থেকে সাজানো আছে, দাম তুলনা করতে পারবেন। দাম: প্রতি ইউনিট ৯৫০.০০ টাকা। ঔষধটি Protein kinase inhibitor শ্রেণির অন্তর্ভুক্ত। Abezino প্রস্তুত করেছে Healthcare Pharmaceuticals Ltd। ডাক্তারের প্রেসক্রিপশন মেনে চলুন এবং অন্য ব্র্যান্ড খাওয়া যাবে কি না তা ফার্মাসিস্টের কাছ থেকে জেনে নিন।

Abemaciclib-এর ৬টি ব্র্যান্ড বাংলাদেশে তালিকাভুক্ত। ইউনিট দামের হিসেবে Abezino এগুলোর মধ্যে সবচেয়ে কম দামিদের একটি। সবচেয়ে কম দাম Abeza 150 mg Tablet-এর, প্রতি ইউনিট ৳ ৯৫০.০০।

Abezino 150 mg Tablet কী?

Made by Healthcare Pharmaceuticals Ltd., Abezino is a tablet whose active ingredient is Abemaciclib. Abezino 150 mg tablet is a cancer medicine containing Abemaciclib, which belongs to a group called protein kinase inhibitors. Because it is a cancer medicine, it is started and supervised only by a qualified cancer specialist. Do not change or stop the medicine unless your doctor tells you to.

Abezino-এর ব্যবহার

It is meant for patients whose doctor has confirmed the cancer type and stage and decided that this medicine is appropriate. Do not use it for any other condition without medical advice. It is not a general-purpose medicine and should only be used under cancer specialist care. Ask your doctor whether it is right for your condition.

Abezino কীভাবে ব্যবহার করবেন

If a dose is missed or vomiting occurs, ask the doctor or pharmacist what to do rather than guessing. Abezino is taken by mouth. Swallow the tablet with water. The doctor decides the dose and how long you take it, and may change the schedule depending on how you tolerate it. Complete the course exactly as prescribed.

Abezino-এর পার্শ্বপ্রতিক্রিয়া

Blood counts can also drop, which may show up as low white cells, low red cells or low platelets. Some people may develop severe diarrhea with dehydration or infection, or lung problems. Your doctor will advise on managing side effects. Contact your doctor if you notice anything unusual after taking it.

সতর্কতা ও নিরাপত্তা

Some medicines, including certain antifungals and antibiotics, can affect how Abemaciclib works, so always tell the doctor or pharmacist about everything you take. Women who could become pregnant should use effective contraception during treatment and for a period after the last dose as advised by the doctor. Tell your doctor if you are pregnant, planning pregnancy or breastfeeding.

সাধারণ প্রশ্ন

What does Abezino treat?

It is meant for patients whose doctor has confirmed the cancer type and stage and decided that this medicine is appropriate. Do not use it for any other condition without medical advice.

How is Abezino used?

If a dose is missed or vomiting occurs, ask the doctor or pharmacist what to do rather than guessing. Abezino is taken by mouth.

What should I watch for while using Abezino?

Blood counts can also drop, which may show up as low white cells, low red cells or low platelets. Some people may develop severe diarrhea with dehydration or infection, or lung problems.

What is the price of Abezino?

The listed price is ৳ ৯৫০.০০.

Tablet
জেনেরিক নাম
Abemaciclib
শক্তি
150 mg
ডোজ ফর্ম
Tablet
প্রস্তুতকারক
Healthcare Pharmaceuticals Ltd.
থেরাপিউটিক ক্লাস
Protein kinase inhibitor
বাংলাদেশে দাম

৳ ৯৩১ ৳ ৯৫০.০০ ২% ছাড় প্রতি ইউনিট

দাম হালনাগাদ: ১৮ Nov ২০২৬

আরও পাওয়া যায়

200 mg (Tablet)

নির্দেশনা

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

Abezino is a kinase inhibitor indicated:
  • in combination with endocrine therapy (tamoxifen or an aromatase inhibitor) for the adjuvant treatment of adult patients with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative, node-positive, early breast cancer at high risk of recurrence and a Ki-67 score ≥20% as determined by an FDA approved test.
  • ... Read more
Abezino is a kinase inhibitor indicated:
  • in combination with endocrine therapy (tamoxifen or an aromatase inhibitor) for the adjuvant treatment of adult patients with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative, node-positive, early breast cancer at high risk of recurrence and a Ki-67 score ≥20% as determined by an FDA approved test.
  • in combination with an aromatase inhibitor as initial endocrine-based therapy for the treatment of postmenopausal women, and men, with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced or metastatic breast cancer.
  • in combination with fulvestrant for the treatment of adult patients with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced or metastatic breast cancer with disease progression following endocrine therapy.
  • as monotherapy for the treatment of adult patients with HR-positive, HER2-negative advanced or metastatic breast cancer with disease progression following endocrine therapy and prior chemotherapy in the metastatic setting.

ফার্মাকোলজি

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

Abemaciclib is an inhibitor of cyclin-dependent kinases 4 and 6 (CDK4 and CDK6). These kinases are activated upon binding to D-cyclins. In estrogen receptor-positive (ER+) breast cancer cell lines, cyclin D1 and CDK4/6 promote phosphorylation of the retinoblastoma protein (Rb), cell cycle progression, and cell proliferation. In vitro, continuous exposure to abemaciclib inhibited Rb phosphorylation and blocked progression from G1 into S phase of the cell cycle, resulting in senescence and apoptosis. In breast cancer xenograft models, abemaciclib dosed daily without interruption as a single agent or in combination with antiestrogens resulted in reduction of tumor size.

মাত্রা ও সেবনবিধি

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

Abemaciclib tablets are taken orally with or without food.
  • Recommended starting dose in combination with fulvestrant, tamoxifen, or an aromatase inhibitor: 150 mg twice daily.
  • Recommended starting dose as monotherapy: 200 mg twice daily.
  • Dosing interruption and/or dose reductions may be required based on individual safety and tolerability.

ঔষধের মিথষ্ক্রিয়া

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

CYP3A Inhibitors: Avoid concomitant use of ketoconazole. Reduce the Abezino dose with concomitant use of other strong and moderate CYP3A inhibitors.
CYP3A Inducers: Avoid concomitant use of strong and moderate CYP3A inducers.

পার্শ্ব প্রতিক্রিয়া

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

Most common adverse reactions (incidence ≥20%) were diarrhea, neutropenia, nausea, abdominal pain, infections, fatigue, anemia, leukopenia, decreased appetite, vomiting, headache, alopecia, and thrombocytopenia.

গর্ভাবস্থায় ও স্তন্যদানকালে

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

Based on findings from animal studies and the mechanism of action, Abemaciclib can cause fetal harm when administered to a pregnant woman. In animal reproduction studies, administration of abemaciclib to pregnant rats during the period of organogenesis caused teratogenicity and decreased fetal weight at maternal exposures that were similar to the human clinical exposure based on area under the curve (AUC) at the maximum recommended human dose. Advise pregnant women of the potential risk to a fetus. Advise females of reproductive potential to use effective contraception during treatment with Abemaciclib and for 3 weeks after the last dose.

সতর্কতা

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

Diarrhea: Abezino can cause severe cases of diarrhea, associated with dehydration and infection. Instruct patients at the first sign of loose stools to initiate antidiarrheal therapy, increase oral fluids, and notify their healthcare provider.

Neutropenia: Monitor complete blood counts prior to the start of Abezino therapy, every 2 weeks for the first 2 months, monthly for the next 2 months, and as clinically indicated.

Interstitial Lung Disease (ILD)/Pneumonitis: Severe and fatal cases of ILD/pneumonitis have been reported. Monitor for clinical symptoms or radiological changes indicative of ILD/pneumonitis. Permanently discontinue Abezino in all patients with Grade 3 or 4 ILD or pneumonitis.

Hepatotoxicity: Increases in serum transaminase levels have been observed. Perform liver function tests (LFTs) before initiating treatment with Abezino. Monitor LFTs every two weeks for the first two months, monthly for the next 2 months, and as clinically indicated.

Venous Thromboembolism: Monitor patients for signs and symptoms of thrombosis and pulmonary embolism and treat as medically appropriate.

Embryo-Fetal Toxicity: Can cause fetal harm. Advise patients of potential

সংরক্ষণ

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

Keep below 30°C temperature, away from light & moisture. Keep out of the reach of children.

বিকল্প ব্র্যান্ড: Abemaciclib

একই জেনেরিকের অন্য ব্র্যান্ড, কম দাম আগে।

Abeclib Tablet

150 mg

Abemaciclib

Eskayef Pharmaceuticals Ltd.

৳ ৯৩১ ৳ ৯৫০.০০ ২% ছাড় প্রতি ইউনিট

Abeza Tablet

150 mg

Abemaciclib

Beacon Pharmaceuticals PLC

৳ ৯৩১ ৳ ৯৫০.০০ ২% ছাড় প্রতি ইউনিট

Abeclib Tablet

200 mg

Abemaciclib

Eskayef Pharmaceuticals Ltd.

৳ ১১২৭ ৳ ১১৫০.০০ ২% ছাড় প্রতি ইউনিট

Abeza Tablet

200 mg

Abemaciclib

Beacon Pharmaceuticals PLC

৳ ১১২৭ ৳ ১১৫০.০০ ২% ছাড় প্রতি ইউনিট

Abezino Tablet

200 mg

Abemaciclib

Healthcare Pharmaceuticals Ltd.

৳ ১১২৭ ৳ ১১৫০.০০ ২% ছাড় প্রতি ইউনিট

ঔষধের তথ্য শুধু জানার জন্য, এটি চিকিৎসা পরামর্শ নয়। সবসময় ডাক্তারের প্রেসক্রিপশন মানুন এবং ফার্মাসিস্টের সাথে কথা বলুন।